低收入和中等收入国家对私营营利性医疗服务提供者的公共管理。

Public stewardship of private for-profit healthcare providers in low- and middle-income countries.

作者信息

Wiysonge Charles S, Abdullahi Leila H, Ndze Valantine N, Hussey Gregory D

机构信息

Centre for Evidence-based Health Care, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, South Africa, 8000.

出版信息

Cochrane Database Syst Rev. 2016 Aug 11;2016(8):CD009855. doi: 10.1002/14651858.CD009855.pub2.

Abstract

BACKGROUND

Governments use different approaches to ensure that private for-profit healthcare services meet certain quality standards. Such government guidance, referred to as public stewardship, encompasses government policies, regulatory mechanisms, and implementation strategies for ensuring accountability in the delivery of services. However, the effectiveness of these strategies in low- and middle-income countries (LMICs) have not been the subject of a systematic review.

OBJECTIVES

To assess the effects of public sector regulation, training, or co-ordination of the private for-profit health sector in low- and middle-income countries.

SEARCH METHODS

For related systematic reviews, we searched the Cochrane Database of Systematic Reviews (CDSR) 2015, Issue 4; Database of Abstracts of Reviews of Effectiveness (DARE) 2015, Issue 1; Health Technology Assessment Database (HTA) 2015, Issue 1; all part of The Cochrane Library, and searched 28 April 2015. For primary studies, we searched MEDLINE, Epub Ahead of Print, In-Process & Other Non-Indexed Citations, MEDLINE Daily and MEDLINE 1946 to Present, OvidSP (searched 16 June 2016); Science Citation Index and Social Sciences Citation Index 1987 to present, and Emerging Sources Citation Index 2015 to present, ISI Web of Science (searched 3 May 2016 for papers citing included studies); Cochrane Central Register of Controlled Trials (CENTRAL), 2015, Issue 3, part of The Cochrane Library (including the Cochrane Effective Practice and Organisation of Care (EPOC) Group Specialised Register) (searched 28 April 2015); Embase 1980 to 2015 Week 17, OvidSP (searched 28 April 2015); Global Health 1973 to 2015 Week 16, OvidSP (searched 30 April 2015); WHOLIS, WHO (searched 30 April 2015); Science Citation Index and Social Sciences Citation Index 1975 to present, ISI Web of Science (searched 30 April 2015); Health Management, ProQuest (searched 22 November 2013). In addition, in April 2016, we searched the reference lists of relevant articles, WHO International Clinical Trials Registry Platform, Clinicaltrials.gov, and various electronic databases of grey literature.

SELECTION CRITERIA

Randomised trials, non-randomised trials, interrupted time series studies, or controlled before-after studies.

DATA COLLECTION AND ANALYSIS

Two authors independently assessed study eligibility and extracted data, comparing their results and resolving discrepancies by consensus. We expressed study results as risk ratios (RR) or mean differences (MD) with 95% confidence intervals (CI), where appropriate, and assessed the certainty of the evidence using Grades of Recommendation, Assessment, Development and Evaluation (GRADE). We did not conduct meta-analysis because of heterogeneity of interventions and study designs.

MAIN RESULTS

We identified 20,177 records, 50 of them potentially eligible. We excluded 39 potentially eligible studies because they did not involve a rigorous evaluation of training, regulation, or co-ordination of private for-profit healthcare providers in LMICs; five studies identified after the review was submitted are awaiting assessment; and six studies met our inclusion criteria. Two included studies assessed training alone; one assessed regulation alone; three assessed a multifaceted intervention involving training and regulation; and none assessed co-ordination. All six included studies targeted private for-profit pharmacy workers in Africa and Asia.Three studies found that training probably increases sale of oral rehydration solution (one trial in Kenya, 106 pharmacies: RR 3.04, 95% CI 1.37 to 6.75; and one trial in Indonesia, 87 pharmacies: RR 1.41, 95% CI 1.03 to 1.93) and dispensing of anti-malarial drugs (one trial in Kenya, 293 pharmacies: RR 8.76, 95% CI 0.94 to 81.81); moderate-certainty evidence.One study conducted in the Lao People's Democratic Republic shows that regulation of the distribution and sale of registered pharmaceutical products may improve composite pharmacy indicators (one trial, 115 pharmacies: improvements in four of six pharmacy indicators; low-certainty evidence).The outcome in three multifaceted intervention studies was the quality of pharmacy practice; including the ability to ask questions, give advice, and provide appropriate treatment. The trials applied regulation, training, and peer influence in sequence; and the study design does not permit separation of the effects of the different interventions. Two trials conducted among 136 pharmacies in Vietnam found that the multifaceted intervention may improve the quality of pharmacy practice; but the third study, involving 146 pharmacies in Vietnam and Thailand, found that the intervention may have little or no effects on the quality of pharmacy practice (low-certainty evidence).Only two studies (both conducted in Vietnam) reported cost data, with no rigorous assessment of the economic implications of implementing the interventions in resource-constrained settings. No study reported data on equity, mortality, morbidity, adverse effects, satisfaction, or attitudes.

AUTHORS' CONCLUSIONS: Training probably improves quality of care (i.e. adherence to recommended practice), regulation may improve quality of care, and we are uncertain about the effects of co-ordination on quality of private for-profit healthcare services in LMICs. The likelihood that further research will find the effect of training to be substantially different from the results of this review is moderate; implying that monitoring of the impact is likely to be needed if training is implemented. The low certainty of the evidence for regulation implies that the likelihood of further research finding the effect of regulation to be substantially different from the results of this review is high. Therefore, an impact evaluation is warranted if government regulation of private for-profit providers is implemented in LMICs. Rigorous evaluations of these interventions should also assess other outcomes such as impacts on equity, cost implications, mortality, morbidity, and adverse effects.

摘要

背景

政府采用不同方法确保私立营利性医疗服务达到一定质量标准。这种政府指导,即公共管理,涵盖政府政策、监管机制以及确保服务提供问责制的实施策略。然而,这些策略在低收入和中等收入国家(LMICs)的有效性尚未成为系统评价的主题。

目的

评估低收入和中等收入国家公共部门对私立营利性医疗部门的监管、培训或协调的效果。

检索方法

对于相关系统评价,我们检索了《Cochrane系统评价数据库》(CDSR)2015年第4期;《效果评价文摘数据库》(DARE)2015年第1期;《卫生技术评估数据库》(HTA)2015年第1期;均为《Cochrane图书馆》的一部分,并于2015年4月28日进行检索。对于原始研究,我们检索了MEDLINE、印刷版之前的Epub、在研及其他未索引引文、MEDLINE日报以及1946年至今的MEDLINE、OvidSP(检索于2016年6月16日);1987年至今的《科学引文索引》和《社会科学引文索引》,以及2015年至今的《新兴资源引文索引》,ISI科学网(检索于2016年5月3日以获取引用纳入研究的论文);《Cochrane对照试验中心注册库》(CENTRAL),2015年第3期,《Cochrane图书馆》的一部分(包括Cochrane有效实践与护理组织(EPOC)小组专业注册库)(检索于2015年4月28日);Embase 1980年至2015年第17周,OvidSP(检索于2015年4月28日);《全球卫生》1973年至2015年第16周,OvidSP(检索于2015年4月30日);世界卫生组织图书馆信息系统(WHOLIS),世界卫生组织(检索于2015年4月30日);1975年至今的《科学引文索引》和《社会科学引文索引》,ISI科学网(检索于2015年4月30日);《卫生管理》,ProQuest(检索于2013年11月22日)。此外,在2016年4月,我们检索了相关文章的参考文献列表、世界卫生组织国际临床试验注册平台、Clinicaltrials.gov以及各种灰色文献电子数据库。

选择标准

随机试验、非随机试验、中断时间序列研究或前后对照研究。

数据收集与分析

两位作者独立评估研究的合格性并提取数据,比较结果并通过共识解决差异。我们在适当情况下将研究结果表示为风险比(RR)或平均差(MD)以及95%置信区间(CI),并使用推荐分级、评估、制定与评价(GRADE)评估证据的确定性。由于干预措施和研究设计的异质性,我们未进行荟萃分析。

主要结果

我们识别出20177条记录,其中50条可能符合条件。我们排除了39条可能符合条件的研究,因为它们未对低收入和中等收入国家私立营利性医疗服务提供者的培训、监管或协调进行严格评估;在综述提交后识别出的5项研究正在等待评估;6项研究符合我们的纳入标准。2项纳入研究仅评估了培训;1项仅评估了监管;3项评估了涉及培训和监管的多方面干预措施;没有研究评估协调情况。所有6项纳入研究的目标均为非洲和亚洲的私立营利性药房工作人员。3项研究发现培训可能会增加口服补液盐的销售量(肯尼亚的1项试验,106家药房:RR 3.04,95%CI 1.37至6.75;印度尼西亚的1项试验,87家药房:RR 1.41,95%CI 1.03至1.93)以及抗疟药物的配药量(肯尼亚的1项试验,293家药房:RR 8.76,95%CI 0.94至81.81);中等确定性证据。在老挝人民民主共和国进行的1项研究表明,对注册药品的分发和销售进行监管可能会改善综合药房指标(1项试验,115家药房:6项药房指标中的4项有所改善;低确定性证据)。3项多方面干预研究的结果是药房实践质量;包括提问、提供建议和提供适当治疗的能力。试验按顺序应用了监管、培训和同伴影响;且研究设计不允许区分不同干预措施的效果。在越南的136家药房中进行的2项试验发现,多方面干预可能会改善药房实践质量;但在越南和泰国的146家药房中进行的第3项研究发现,该干预措施可能对药房实践质量几乎没有影响或没有影响(低确定性证据)。只有2项研究(均在越南进行)报告了成本数据,且未对在资源受限环境中实施干预措施的经济影响进行严格评估。没有研究报告关于公平性、死亡率、发病率、不良反应、满意度或态度的数据。

作者结论

培训可能会提高医疗质量(即遵循推荐实践),监管可能会提高医疗质量,而我们不确定协调对低收入和中等收入国家私立营利性医疗服务质量的影响。进一步研究发现培训效果与本综述结果有实质性差异的可能性为中等;这意味着如果实施培训,可能需要监测其影响。监管证据的低确定性意味着进一步研究发现监管效果与本综述结果有实质性差异的可能性很高。因此,如果在低收入和中等收入国家对私立营利性提供者实施政府监管,则有必要进行影响评估。对这些干预措施的严格评估还应评估其他结果,如对公平性的影响、成本影响、死亡率、发病率和不良反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57b1/6457601/b1cc04a6d69c/nCD009855-AFig-FIG01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索